ArticleCureus2025
Artificial Intelligence-Driven Approaches to Endoscopic Gastric Cancer Detection: Current Progress and Future Directions.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- World Endoscopy Organization Position Statements for Artificial Intelligence in Endoscopic Diagnosis of Gastric Epithelial Neoplasia.Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society · 2026Review
- Artificial intelligence assistance improves endoscopist accuracy for gastric cancer dysplasia and intestinal metaplasia.Scientific reports · 2026Article
- Artificial intelligence and machine learning-driven advancements in gastrointestinal cancer: Paving the way for precision medicine.World journal of gastroenterology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gastric cancer (GC) is one of the most prevalent and lethal cancers globally, with early detection being crucial for improving patient survival rates. Endoscopy remains the primary diagnostic tool for gastric cancer, but its accuracy is highly dependent on the endoscopist's skill. Misdiagnosis rates, caused by factors such as incomplete lesion recognition and operator errors, remain a significant challenge. Artificial intelligence (AI), particularly deep learning models like convolutional neural networks (CNNs), has shown substantial potential in enhancing the detection of gastric cancer during endoscopic procedures. AI-driven systems have demonstrated the ability to improve diagnostic accuracy, reduce missed lesions, and standardize assessments, regardless of endoscopist experience. Studies have highlighted AI's effectiveness, with some models achieving diagnostic accuracy comparable to senior practitioners. However, challenges such as data quality, false positives/negatives, geographical biases, and regulatory barriers need to be addressed for broader clinical implementation. Despite these limitations, ongoing advancements in AI technology, coupled with multinational research and improved dataset diversity, hold promise for improving the early detection of gastric cancer, enhancing patient outcomes, and optimizing clinical workflows.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.